logo

For the Inventor, By the Inventor

Jan T Vilcek

New York, NY, United States of America

Jan T Vilcek

wikipedia

This inventor holds 46 USPTO granted patents and 4 published patent applications, primarily in Anti-TNF Therapeutics. Top assignees: New York University, Centocor, Inc., Japanese Foundation for Cancer Research. Active years: 1984-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jan T Vilcek. Retrieved from https://idiyas.com/inventor/jan-t-vilcek

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 46 

% Patents Active = 30.4

Average Co-Inventor Count = 5.1

ph-index = 18

Forward Citations = 1,874(Granted Patents)


Company Filing History:

goldMedal41 out of 1,727 
 
New York University
 patents
silverMedal34 out of 144 
 
Centocor, Inc.
 patents
bronzeMedal1 out of 57 
 
Japanese Foundation for Cancer Research
 patents
4. 4 out of 834,453 
Other
 patents
where one patent can have more than one assignee

Years Active: 1984-2010

Loading Chart...
Areas of Expertise:
Anti-TNF Antibodies
Rheumatoid Arthritis
Psoriasis
Vascular Inflammation
Chimeric Antibodies
Tumor Necrosis Factor
Crohn's Disease
Cancer Treatment
Inflammatory Pathologies
Pharmaceutical Compositions
Immunoassay Methods
Peptides
46 patents (USPTO):Explore Patents
1. 7744885 - Methods of treating vascular inflammatory pathology using anti-TNF antibodies and fragments thereof (2010-06-29),
2. 7425330 - Methods of inhibiting TNFα activity in the blood of a patient (2008-09-16),
3. 7416729 - Methods of treating rheumatoid arthritis with anti-TNF antibodies (2008-08-26),
4. 7404955 - Methods of inhibiting or neutralizing TNFα in patients with tissue injury (2008-07-29),
5. 7374761 - Recombinant A2-specific TNFα-specific antibodies (2008-05-20),
6. 7335358 - Methods of treating psoriasis with anti-TNF antibodies (2008-02-26),
7. 7276239 - Recombinant A2-specific TNFα-specific antibodies (2007-10-02),
8. 7252823 - Recombinant A2-specific TNFα-specific antibodies (2007-08-07),
9. 7227003 - Anti-TNF antibody fragments (2007-06-05),
10. 7226593 - Methods of treating cachexia with chimeric anti-TNF antibodies (2007-06-05),
11. 7223396 - Methods of treatment of fistulas in Crohn's disease with anti-TNF antibodies (2007-05-29),
12. 7214376 - Methods of inhibiting TNFα in patients with neoplastic disease (2007-05-08),
13. 7204985 - Methods of treating disseminated intravascular coagulation by multiple administration of anti-TNF antibodies (2007-04-17),
14. 7192584 - Methods of treating psoriasis with anti-TNF antibodies (2007-03-20),
15. 7179893 - Recombinant anti-TNF-α antibodies (2007-02-20),

Title: Jan T Vilcek - Pioneering Inventor from New York

Introduction: Jan T Vilcek is a renowned inventor based in New York, NY, known for his groundbreaking contributions to the field of biotechnology and medicine.

Latest Patents: Jan T Vilcek holds several patents in the areas of immunology and pharmaceuticals, with his most recent inventions focusing on novel drug delivery systems and targeted therapies for autoimmune diseases.

Career Highlights: With a distinguished career spanning several decades, Jan T Vilcek has made significant advancements in the development of biologic drugs, particularly in the treatment of inflammatory disorders. His work has revolutionized the way certain diseases are managed and has improved the quality of life for countless patients worldwide.

Collaborations: Throughout his career, Jan T Vilcek has collaborated with leading researchers, pharmaceutical companies, and academic institutions to further the field of biotechnology. His partnerships have resulted in innovative solutions that have had a lasting impact on the healthcare industry.

Conclusion: Jan T Vilcek's relentless pursuit of innovation and his commitment to improving healthcare have solidified his reputation as a pioneering inventor in the field of biotechnology. His contributions continue to inspire future generations of inventors and researchers to push the boundaries of what is possible in the world of medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…